Rite Aid Corp. (NYSE: RAD) just can’t seem to get it right. Whatever the strategy is intended to be doing, it needs a real change in the world of a CVS, Walgreen, and Wal-Mart dominance. The drug store chain just reported a wider loss than expected and this is getting to be just about enough for even the most patient investors in the world.
The company reported a second-quarter adjust loss of -$0.18 EPS versus Thomson Reuters estimates of -$0.17 EPS. Revenue was also a tad light for the quarter at $6.16 billion, which is under the estimate of $6.21 billion. Meanwhile, comparable store sales fell 1.5% in the second quarter.
But wait, there’s more. The company has lowered its Fiscal-2011 guidance from a loss of -$0.41 to -$0.65 down to a slightly wider loss of -$0.46 to -$0.67. On the sales front, Rite Aid now expects $25.0 to $25.4 billion from a prior range of $25.2 to $25.6 billion.
Unless the company is announcing a whole new management team and a whole new strategy, this is likely to remain a huge conundrum. Rite Ad is a stock which could still double, but it could also ultimately end up on the garbage pile. After years and years, it remains a turnaround which just will not turn around.
JON C. OGG
Sponsored: Find a Qualified Financial Advisor
Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
